Detalhe da pesquisa
1.
SGLT2 inhibitor empagliflozin alleviates cardiac remodeling and contractile anomalies in a FUNDC1-dependent manner in experimental Parkinson's disease.
Acta Pharmacol Sin
; 45(1): 87-97, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37679644
2.
Profiling microRNA from Brain by Microarray in a Transgenic Mouse Model of Alzheimer's Disease.
Biomed Res Int
; 2017: 8030369, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29057267